Paired-Fraction Electrochemical Programming of Ligase-Mediated Peptide Macrocyclization

A simple head-to-tail cyclic peptide is proposed as the fourth step of a PFEP validation ladder using Omniligase-1, a catalogued recombinant peptide ligase, subject to confirmation of current supply and lot activity. The model precursor is a 14-residue, side-chain-unprotected linear peptide with a free N terminus and an activated C-terminal carboxyamidomethyl ester. Its junction must avoid proline in the P1, P1-prime, and P2-prime positions and should provide a favourable hydrophobic P4 residue. The ligase therefore determines the precursor; PFEP cannot make an incompatible sequence cyclizable. The proposed role of paired electrochemical fractions is limited to ex situ control of enzyme-compatible pH, ionic strength, reducing environment, substrate solubility, and timed acidic quench while ligation occurs in an electrode-free vessel. Controls include optimized buffer, conventional pH-stat, each fraction alone, premixed fractions, and full chemical reconstruction. LC-MS, end-group analysis, and orthogonal structural evidence must distinguish cyclic monomer from linear isobaric material and oligomers. No cyclization result is claimed. Article type: Perspective, mechanistic hypothesis, and experimental framework. No experimental peptide yield, potency, clinical effect, or shelf-life evidence is reported.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-15
DOI
https://doi.org/10.5281/zenodo.23382134
Primary Topic
Chemical Synthesis and Analysis
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Paired-Fraction Electrochemical Programming of Ligase-Mediated Peptide Macrocyclization

Ilyan Kan
Zenodo (CERN European Organization for Nuclear Research)
Chemical Synthesis and Analysis
preprint

Paired-Fraction Electrochemical Programming of Ligase-Mediated Peptide Macrocyclization

Ilyan Kan
preprint en

Abstract

A simple head-to-tail cyclic peptide is proposed as the fourth step of a PFEP validation ladder using Omniligase-1, a catalogued recombinant peptide ligase, subject to confirmation of current supply and lot activity. The model precursor is a 14-residue, side-chain-unprotected linear peptide with a free N terminus and an activated C-terminal carboxyamidomethyl ester. Its junction must avoid proline in the P1, P1-prime, and P2-prime positions and should provide a favourable hydrophobic P4 residue. The ligase therefore determines the precursor; PFEP cannot make an incompatible sequence cyclizable. The proposed role of paired electrochemical fractions is limited to ex situ control of enzyme-compatible pH, ionic strength, reducing environment, substrate solubility, and timed acidic quench while ligation occurs in an electrode-free vessel. Controls include optimized buffer, conventional pH-stat, each fraction alone, premixed fractions, and full chemical reconstruction. LC-MS, end-group analysis, and orthogonal structural evidence must distinguish cyclic monomer from linear isobaric material and oligomers. No cyclization result is claimed. Article type: Perspective, mechanistic hypothesis, and experimental framework. No experimental peptide yield, potency, clinical effect, or shelf-life evidence is reported.

Zenodo (CERN European Organization for Nuclear Research)
University of Toronto (CA)
Chemical Synthesis and Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.